Kathleen D. Scott is Chief Financial Officer of ARS Pharmaceuticals Inc.
Person profile
Roles
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
NKGen Biotech, Inc.
14 Feb 24
4
Dermata Therapeutics, Inc.
5 Jan 24
4
ARS Pharmaceuticals, Inc.
4 Jan 24
3
NKGen Biotech, Inc.
10 Oct 23
4
ARS Pharmaceuticals, Inc.
5 Jan 23
4
ARS Pharmaceuticals, Inc.
1 Dec 22
4
ARS Pharmaceuticals, Inc.
10 Nov 22
3
ARS Pharmaceuticals, Inc.
10 Nov 22
4
Dermata Therapeutics, Inc.
7 Oct 22
4
Dermata Therapeutics, Inc.
8 Jul 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Feb 24 | NKGN NKGen Biotech | Stock Option Common Stock | Grant | Acquire A | No | No | 1.62 | 300,000 | 486.00 k | 300,000 |
4 Jan 24 | DRMA Dermata Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6099 | 10,000 | 6.10 k | 10,000 |
2 Jan 24 | SPRY ARS Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 5.58 | 200,000 | 1.12 mm | 200,000 |
3 Jan 23 | SPRY ARS Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 8.42 | 50,000 | 421.00 k | 50,000 |